阿尔茨海默病诊断标准:从临床诊断到病理生理诊断

doi:10.6040/j.issn.1671-7554.0.2017.320

Abstract

Abstract: Alzheimers disease(AD)is the leading cause of dementia and the most prevalent neurodegenerative disease in the elderly. The first diagnostic criteria was developed by the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimers Disease and Related Disorders Association Work Group in 1984. With the further understanding of pathophysiological mechanism underlying AD, two new sets of research criteria for Alzheimers 山东大学学报 (医学版)55卷10期 -唐毅.阿尔茨海默病诊断标准:从临床诊断到病理生理诊断 \=-disease were proposed: those published by an International Working Group in 2007, which was updated in 2014, and the recommendations published by the National Institute on Aging and the Alzheimers Association(NIA-AA)in 2011. A comparison of the criteria is needed for clinical practice and research purpose.

Key words: Alzheimers disease, Diagnostic criteria, Biomarker, Preclinical AD

CLC Number:

R741.04

TANG Yi. Evolution of diagnostic criteria for Alzheimers disease: from clinical diagnosis to pathophysiological diagnosis[J].JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 14-20.

References

[1] McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimers disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimers Disease[J]. Neurology, 1984, 34(7): 939-944.
[2] Morris JC, Blennow K, Froelich L, et al. Harmonized diagnostic criteria for Alzheimers disease: recommendations[J]. J Intern Med, 2014, 275(3): 204-213.
[3] Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria[J]. Lancet Neuro, 2007, 6(8): 734-746.
[4] Dubois B, Feldman HH, Jacova C, et al. Advancing research diagnostic criteria for Alzheimers disease: the IWG-2 criteria[J]. Lancet Neuro, 2014, 13(6): 614-629.
[5] Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimers disease: recommendations from the National Institute on Aging-Alzheimers Association workgroups on diagnostic guidelines for Alzheimers disease[J]. Alzheimers Dement, 2011, 7(3): 280-292.
[6] Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimers disease: recommendations from the National Institute on Aging-Alzheimers Association workgroups on diagnostic guidelines for Alzheimers disease[J]. Alzheimers Dement, 2011, 7(3): 270-279.
[7] McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimers disease: recommendations from the National Institute on Aging-Alzheimers Association workgroups on diagnostic guidelines for Alzheimers disease[J]. Alzheimers Dement, 2011, 7(3): 263-269.
[8] Baldereschi M, Amato MP, Nencini P, et al. Cross-national interrater agreement on the clinical diagnostic criteria for dementia. WHO-PRA Age-Associated Dementia Working Group, WHO-Program for Research on Aging, Health of Elderly Program[J]. Neurology, 1994, 44(2): 239-242.
[9] Hjortso S, Butler B, Clemmesen L, et al. The use of case vignettes in studies of interrater reliability of psychiatric target syndromes and diagnoses. A comparison of ICD-8, ICD-10 and DSM-III[J]. Acta Psychiatr Scand, 1989, 80(6): 632-638.
[10] Graham JE, Rockwood K, Beattie BL, et al. Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging[J]. Neuroepidemiology, 1996, 15(5): 246-256.
[11] Larson EB, McCurry SM, Graves AB, et al. Standardization of the clinical diagnosis of the dementia syndrome and its subtypes in a cross-national study: the Ni-Hon-Sea experience[J]. J Gerontol A Biol Sci Med Sci, 1998, 53(4): M313-319.
[12] Fratiglioni L, Grut M, Forsell Y, et al. Clinical diagnosis of Alzheimers disease and other dementias in a population survey. Agreement and causes of disagreement in applying Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition, Criteria[J]. Arch Neurol, 1992, 49(9): 927-932.
[13] Lim A, Tsuang D, Kukull W, et al. Clinico-neuropathological correlation of Alzheimers disease in a community-based case series[J]. J Am Geriatr Soc, 1999, 47(5): 564-569.
[14] Varma AR, Snowden JS, Lloyd JJ, et al. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimers disease and frontotemporal dementia[J]. J Neurol Neurosurg Psychiatry, 1999, 66(2): 184-188.
[15] Ranginwala NA, Hynan LS, Weiner MF, et al. Clinical criteria for the diagnosis of Alzheimer disease: still good after all these years[J]. Am J Geriatr Psychiatry, 2008, 16(5): 384-388.
[16] Morris JC. Early-stage and preclinical Alzheimer disease[J]. Alzheimer Dis Assoc Disord, 2005, 19(3): 163-165.
[17] Kazee AM, Eskin TA, Lapham LW, et al. Clinicopathologic correlates in Alzheimer disease: assessment of clinical and pathologic diagnostic criteria[J]. Alzheimer Dis Assoc Disord, 1993, 7(3): 152-164.
[18] Dubois B, Feldman HH, Jacova C, et al. Revising the definition of Alzheimers disease: a new lexicon[J]. Lancet Neuro, 2010, 9(11): 1118-1127.
[19] Aizenstein HJ, Nebes RD, Saxton JA, et al. Frequent amyloid deposition without significant cognitive impairment among the elderly[J]. Arch Neurol, 2008, 65(11): 1509-1517.
[20] Price JL, Morris JC. Tangles and plaques in nondemented aging and “preclinical” Alzheimers disease[J]. Ann Neurol, 1999, 45(3): 358-368.
[21] Bennett DA, Schneider JA, Arvanitakis Z, et al. Neuropathology of older persons without cognitive impairment from two community-based studies[J]. Neurology, 2006, 66(12): 1837-1844.
[22] Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimers disease: recommendations from the National Institute on Aging-Alzheimers Association Workgroups on diagnostic guidelines for Alzheimers disease[J]. Alzheimers Dement, 2011, 7(3): 280-292.
[23] Slaets S, Le Bastard N, Theuns J, et al. Amyloid pathology influences abeta1-42 cerebrospinal fluid levels in dementia with lewy bodies[J]. J Alzheimers Dis, 2013, 35(1): 137-146.
[24] Perret-Liaudet A, Pelpel M, Tholance Y, et al. Risk of Alzheimers disease biological misdiagnosis linked to cerebrospinal collection tubes[J]. J Alzheimers Dis, 2012, 31(1): 13-20.
[25] Bian H, Van Swieten JC, Leight S, et al. CSF biomarkers in frontotemporal lobar degeneration with known pathology[J]. Neurology, 2008, 70(19 Pt 2): 1827-1835.
[26] Schoonenboom NS, Reesink FE, Verwey NA, et al. Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort[J]. Neurology, 2012, 78(1): 47-54.
[27] de Souza LC, Lamari F, Belliard S, et al. Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimers disease from other cortical dementias[J]. J Neurol Neurosurg Psychiatry, 2011, 82(3): 240-246.
[28] Brys M, Pirraglia E, Rich K, et al. Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment[J]. Neurobiol Aging, 2009, 30(5): 682-690.
[29] de Jager CA, Honey TE, Birks J, et al. Retrospective evaluation of revised criteria for the diagnosis of Alzheimers disease using a cohort with post-mortem diagnosis[J]. Int J Geriatr Psychiatry, 2010, 25(10): 988-997.
[30] Harris JM, Thompson JC, Gall C, et al. Do NIA-AA criteria distinguish Alzheimers disease from frontotemporal dementia?[J]. Alzheimers Dement, 2015, 11(2): 207-215.
[31] Visser PJ, Vos S, van Rossum I, et al. Comparison of International Working Group criteria and National Institute on Aging-Alzheimers Association criteria for Alzheimers disease[J]. Alzheimers Dement, 2012, 8(6): 560-563.
[32] Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on mild cognitive impairment[J]. J Intern Med, 2004, 256(3): 240-246.
[33] 王晓妮, 唐毅, 韩璎.阿尔茨海默病诊断标准的演变[J].医学研究生学报, 2015, 28(2): 195-198. WANG Xiaoni, TANG Yi, HAN Ying. The evolution of criteria for the diagnosis of Alzheimers disease[J].J Med Postgra, 2015, 28(2): 195-198.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Comments

Recommended 0

No Suggested Reading articles found!

Evolution of diagnostic criteria for Alzheimers disease: from clinical diagnosis to pathophysiological diagnosis

PDF (PC)

Abstract

Cite this article

share this article

References

Related Articles 8

Metrics

Comments

Recommended 0

[1]	DU Yifeng, JING Ran. Diagnosis and treatment of Alzheimers disease [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 7-13.
[2]	FANG Qian, QU Ailin, ZHANG Xin, DU Lutao, YANG Yongmei, WANG Chuanxin. Expression and clinical significance of miR-210 in the serum of patients with colorectal cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(6): 77-81.
[3]	GAO Nannan, CHEN Dong, YU Yonghui, ZHANG Lili. Significance of different biomarkers on assessing the surgical treatment of necrotizing enterocolitis in the newborn [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(6): 73-76.
[4]	LIU Xin-nong, ZHAN Han-xiang, HU San-yuan, ZHANG Guang-yong, WANG Lei . The role of serum miR-146a in early diagnosis of sepsis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(9): 92-94.
[5]	HAN Bo1,3, YANG Xiao-qing1, ZHANG Jing2, LIU Wen-jun3, LIU Long3. Role of SPINK1 in prostate cancer: advances in experimental and translational research [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(8): 40-.
[6]	WANG Xiao-hua1, GAO Shu-chun1, CUI Lei2, JIANG Xue-mei1, DU Yi-zhen1. Serum interlukine-28B expression in HBV related primary hepatocellular carcinoma patients and its significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(10): 106-110.
[7]	KONG Xiang-gen1, HAN Shao-lei2, ZHENG Zhao-min2, DU Wen-jun2, CHEN Shi-jun2. Values of Golgi protein 73 and Alpha-fetoprotein-L3 in the diagnosis of primary hepatic carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(4): 110-114.
[8]	BAI Shu-mei,LIU Shi-lian,YANG Yin-rong,GUO Xu-xiao,QIN Yan-jiang,DENG Xiao-mei. Potential biomarkers in RRMS [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(4): 340-343.